648 related articles for article (PubMed ID: 30562794)
1. [Immunometabolism and systemic lupus erythematosus].
Xiao YB; Guo MY; Zuo XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
[TBL] [Abstract][Full Text] [Related]
2. Immunometabolism in systemic lupus erythematosus.
Morel L
Nat Rev Rheumatol; 2017 May; 13(5):280-290. PubMed ID: 28360423
[TBL] [Abstract][Full Text] [Related]
3. A cellular overview of immunometabolism in systemic lupus erythematosus.
Psarras A; Clarke A
Oxf Open Immunol; 2023; 4(1):iqad005. PubMed ID: 37554724
[TBL] [Abstract][Full Text] [Related]
4. B cell activation via immunometabolism in systemic lupus erythematosus.
Iwata S; Hajime Sumikawa M; Tanaka Y
Front Immunol; 2023; 14():1155421. PubMed ID: 37256149
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
Iwata S; Tanaka Y
Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen up-regulates interleukin-21 production by CD4(+) T lymphocytes in patients with systemic lupus erythematosus.
Lee J; Shin EK; Lee SY; Her YM; Park MK; Kwok SK; Ju JH; Park KS; Kim HY; Cho ML; Park SH
Immunology; 2014 Aug; 142(4):573-80. PubMed ID: 24495300
[TBL] [Abstract][Full Text] [Related]
7. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
Tzeng HT; Chyuan IT
J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Factors that Contribute to Lupus Pathogenesis.
Li W; Sivakumar R; Titov AA; Choi SC; Morel L
Crit Rev Immunol; 2016; 36(1):75-98. PubMed ID: 27480903
[TBL] [Abstract][Full Text] [Related]
9. Immunometabolism in the pathogenesis of systemic lupus erythematosus: an update.
Romo-Tena J; Kaplan MJ
Curr Opin Rheumatol; 2020 Nov; 32(6):562-571. PubMed ID: 32826478
[TBL] [Abstract][Full Text] [Related]
10. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
11. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
12. B-cell-targeted therapy for systemic lupus erythematosus.
Sabahi R; Anolik JH
Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
[TBL] [Abstract][Full Text] [Related]
13. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus?
Gilbert D; Brard F; Jovelin F; Tron F
J Autoimmun; 1996 Apr; 9(2):247-57. PubMed ID: 8738970
[TBL] [Abstract][Full Text] [Related]
14. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions.
Saadh MJ; Kazemi K; Khorramdelazad H; Mousavi MJ; Noroozi N; Masoumi M; Karami J
Int Immunopharmacol; 2023 Jun; 119():110246. PubMed ID: 37148769
[TBL] [Abstract][Full Text] [Related]
15. TIGIT signalling pathway negatively regulates CD4
Mao L; Hou H; Wu S; Zhou Y; Wang J; Yu J; Wu X; Lu Y; Mao L; Bosco MJ; Wang F; Sun Z
Immunology; 2017 Jul; 151(3):280-290. PubMed ID: 28108989
[TBL] [Abstract][Full Text] [Related]
16. B-cell subsets, signaling and their roles in secretion of autoantibodies.
Iwata S; Tanaka Y
Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261
[TBL] [Abstract][Full Text] [Related]
17. Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus.
Zhao M; Wang J; Liao W; Li D; Li M; Wu H; Zhang Y; Gershwin ME; Lu Q
J Autoimmun; 2016 May; 69():64-73. PubMed ID: 26984631
[TBL] [Abstract][Full Text] [Related]
18. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
19. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
[TBL] [Abstract][Full Text] [Related]
20. Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus.
Wu Y; Cai B; Feng W; Yang B; Huang Z; Zuo C; Wang L
Indian J Med Res; 2014 Oct; 140(4):513-9. PubMed ID: 25488445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
